Astec LifeSciences Limited clarified there are no undisclosed material developments explaining the recent significant increase in share trading volume. The company confirmed full compliance with SEBI listing regulations.
Astec LifeSciences responded to an NSE surveillance query on volume spurt. The company confirmed no developments requiring mandatory disclosure under LODR or PIT Regulations.
Astec LifeSciences replied to an NSE volume-spike surveillance notice, confirming full disclosure compliance. No undisclosed developments exist under Listing or PIT Regulations.
Astec LifeSciences clarified to NSE that recent volume spurts are market-driven with no undisclosed developments. The company maintains full compliance with all SEBI disclosure regulations.
Astec LifeSciences Limited clarified to NSE that there are no undisclosed price-sensitive developments or events requiring disclosure under SEBI regulations. The company confirmed compliance with all listing and insider trading regulations, stating that recent share price movements are market-driven and not linked to any internal corporate actions.
Astec LifeSciences Ltd clarified to BSE that there are no undisclosed price-sensitive developments or events requiring disclosure under SEBI regulations. The company confirmed compliance with all listing and insider trading regulations. This response follows a clarification sought by the exchange regarding recent share price movement.